Targeting Gas6/TAM in cancer cells and tumor microenvironment

Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested fibroblasts. Gas6 is a member of the vitamin K-dependent family of proteins expressed in many human tissues and regulates several biological proces...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer Vol. 17; no. 1; pp. 20 - 10
Main Authors Wu, Guiling, Ma, Zhiqiang, Cheng, Yicheng, Hu, Wei, Deng, Chao, Jiang, Shuai, Li, Tian, Chen, Fulin, Yang, Yang
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 31.01.2018
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested fibroblasts. Gas6 is a member of the vitamin K-dependent family of proteins expressed in many human tissues and regulates several biological processes in cells, including proliferation, survival and migration, by binding to its receptors Tyro3, Axl and Mer (TAM). In recent years, the roles of Gas6/TAM signalling in cancer cells and the tumour microenvironment have been studied, and some progress has made in targeted therapy, providing new potential directions for future investigations of cancer treatment. In this review, we introduce the Gas6 and TAM receptors and describe their involvement in different cancers and discuss the roles of Gas6 in cancer cells, the tumour microenvironment and metastasis. Finally, we introduce recent studies on Gas6/TAM targeting in cancer therapy, which will assist in the experimental design of future analyses and increase the potential use of Gas6 as a therapeutic target for cancer.
AbstractList Abstract Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested fibroblasts. Gas6 is a member of the vitamin K-dependent family of proteins expressed in many human tissues and regulates several biological processes in cells, including proliferation, survival and migration, by binding to its receptors Tyro3, Axl and Mer (TAM). In recent years, the roles of Gas6/TAM signalling in cancer cells and the tumour microenvironment have been studied, and some progress has made in targeted therapy, providing new potential directions for future investigations of cancer treatment. In this review, we introduce the Gas6 and TAM receptors and describe their involvement in different cancers and discuss the roles of Gas6 in cancer cells, the tumour microenvironment and metastasis. Finally, we introduce recent studies on Gas6/TAM targeting in cancer therapy, which will assist in the experimental design of future analyses and increase the potential use of Gas6 as a therapeutic target for cancer.
Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested fibroblasts. Gas6 is a member of the vitamin K-dependent family of proteins expressed in many human tissues and regulates several biological processes in cells, including proliferation, survival and migration, by binding to its receptors Tyro3, Axl and Mer (TAM). In recent years, the roles of Gas6/TAM signalling in cancer cells and the tumour microenvironment have been studied, and some progress has made in targeted therapy, providing new potential directions for future investigations of cancer treatment. In this review, we introduce the Gas6 and TAM receptors and describe their involvement in different cancers and discuss the roles of Gas6 in cancer cells, the tumour microenvironment and metastasis. Finally, we introduce recent studies on Gas6/TAM targeting in cancer therapy, which will assist in the experimental design of future analyses and increase the potential use of Gas6 as a therapeutic target for cancer.Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested fibroblasts. Gas6 is a member of the vitamin K-dependent family of proteins expressed in many human tissues and regulates several biological processes in cells, including proliferation, survival and migration, by binding to its receptors Tyro3, Axl and Mer (TAM). In recent years, the roles of Gas6/TAM signalling in cancer cells and the tumour microenvironment have been studied, and some progress has made in targeted therapy, providing new potential directions for future investigations of cancer treatment. In this review, we introduce the Gas6 and TAM receptors and describe their involvement in different cancers and discuss the roles of Gas6 in cancer cells, the tumour microenvironment and metastasis. Finally, we introduce recent studies on Gas6/TAM targeting in cancer therapy, which will assist in the experimental design of future analyses and increase the potential use of Gas6 as a therapeutic target for cancer.
Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested fibroblasts. Gas6 is a member of the vitamin K-dependent family of proteins expressed in many human tissues and regulates several biological processes in cells, including proliferation, survival and migration, by binding to its receptors Tyro3, Axl and Mer (TAM). In recent years, the roles of Gas6/TAM signalling in cancer cells and the tumour microenvironment have been studied, and some progress has made in targeted therapy, providing new potential directions for future investigations of cancer treatment. In this review, we introduce the Gas6 and TAM receptors and describe their involvement in different cancers and discuss the roles of Gas6 in cancer cells, the tumour microenvironment and metastasis. Finally, we introduce recent studies on Gas6/TAM targeting in cancer therapy, which will assist in the experimental design of future analyses and increase the potential use of Gas6 as a therapeutic target for cancer.
ArticleNumber 20
Audience Academic
Author Chen, Fulin
Wu, Guiling
Jiang, Shuai
Ma, Zhiqiang
Li, Tian
Hu, Wei
Deng, Chao
Yang, Yang
Cheng, Yicheng
Author_xml – sequence: 1
  givenname: Guiling
  surname: Wu
  fullname: Wu, Guiling
– sequence: 2
  givenname: Zhiqiang
  surname: Ma
  fullname: Ma, Zhiqiang
– sequence: 3
  givenname: Yicheng
  surname: Cheng
  fullname: Cheng, Yicheng
– sequence: 4
  givenname: Wei
  surname: Hu
  fullname: Hu, Wei
– sequence: 5
  givenname: Chao
  surname: Deng
  fullname: Deng, Chao
– sequence: 6
  givenname: Shuai
  surname: Jiang
  fullname: Jiang, Shuai
– sequence: 7
  givenname: Tian
  surname: Li
  fullname: Li, Tian
– sequence: 8
  givenname: Fulin
  surname: Chen
  fullname: Chen, Fulin
– sequence: 9
  givenname: Yang
  orcidid: 0000-0002-1163-2359
  surname: Yang
  fullname: Yang, Yang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29386018$$D View this record in MEDLINE/PubMed
BookMark eNp9kktrFTEUx4NU7EM_gBsZcONm2snkvVC4FK2Fipu7D2fyuKbMJDWZW-i3N-PU0isiWSQ553f-nNcpOoopOoTe4u4cY8kvCu4VJW2HZdsJrlr8Ap1gKnhLmZJHz97H6LSU267DQgr6Ch33ikhew07Qxy3knZtD3DVXUPjFdvOtCbExEI3LjXHjWBqItpn3U8rNFExOLt6HnOLk4vwavfQwFvfm8T5D2y-ft5df25vvV9eXm5vWMNLPrZeDAd8bTs0gqQSCrSJe1j-xnA7MWOVAVieRrCcdHyTzDBwAFxagJ2foepW1CW71XQ4T5AedIOjfhpR3GvIczOg0sYTxwbluYJw67JWx3AtLlBO-Z6yrWp9Wrbv9MDlrahUZxgPRQ08MP_Qu3WsmFKFYVIEPjwI5_dy7MusplKVREF3aF42VIkT2QuKKvl_RHdTUQvSpKpoF1xtGOamkkpU6_wdVj3W133XiPlT7QcC75yU85f5nqhXAK1CnVUp2_gnBnV42R6-boyusl83RS67irxgTZphDWroQxv9E_gLcFcbZ
CitedBy_id crossref_primary_10_1016_j_yexmp_2020_104600
crossref_primary_10_1016_j_heliyon_2023_e23266
crossref_primary_10_1186_s12964_019_0377_8
crossref_primary_10_1186_s13045_021_01198_9
crossref_primary_10_3390_cancers12061454
crossref_primary_10_3389_fimmu_2023_1135373
crossref_primary_10_1016_j_arr_2018_03_004
crossref_primary_10_3389_fphar_2021_730241
crossref_primary_10_1177_1073274820945975
crossref_primary_10_1080_15384101_2024_2355825
crossref_primary_10_1186_s13045_023_01467_9
crossref_primary_10_1007_s00018_024_05542_3
crossref_primary_10_3389_fcell_2021_759691
crossref_primary_10_3390_ijms24076257
crossref_primary_10_1016_j_dcmed_2020_06_002
crossref_primary_10_1016_j_yexcr_2024_114324
crossref_primary_10_1111_jcmm_14435
crossref_primary_10_1038_s41573_023_00846_8
crossref_primary_10_1016_j_abb_2023_109578
crossref_primary_10_1016_j_ejmech_2023_116045
crossref_primary_10_1021_jacs_9b10460
crossref_primary_10_1158_1535_7163_MCT_18_1399
crossref_primary_10_1016_j_phrs_2023_106668
crossref_primary_10_1159_000529898
crossref_primary_10_1016_j_jare_2024_01_014
crossref_primary_10_7717_peerj_16426
crossref_primary_10_2147_LCTT_S305484
crossref_primary_10_1002_ctm2_1155
crossref_primary_10_1016_j_lfs_2018_02_033
crossref_primary_10_1038_s41598_020_64371_z
crossref_primary_10_1186_s12964_020_0521_5
crossref_primary_10_3389_fcell_2021_779319
crossref_primary_10_1016_j_freeradbiomed_2023_11_007
crossref_primary_10_1007_s12272_019_01169_2
crossref_primary_10_1111_1759_7714_14689
crossref_primary_10_18632_aging_205483
crossref_primary_10_3390_cells9112342
crossref_primary_10_1182_blood_2018_10_878645
crossref_primary_10_1136_gutjnl_2021_325272
crossref_primary_10_1042_BSR20190389
crossref_primary_10_1007_s00262_019_02421_w
crossref_primary_10_1002_ijc_31338
crossref_primary_10_1002_jcp_29782
crossref_primary_10_1016_j_tet_2019_01_005
crossref_primary_10_1002_jcp_31162
crossref_primary_10_3390_cancers13194864
crossref_primary_10_3389_fmolb_2023_1298457
crossref_primary_10_1016_j_ctrv_2023_102639
crossref_primary_10_1016_j_gendis_2021_10_003
crossref_primary_10_1186_s12943_021_01338_2
crossref_primary_10_1126_sciadv_abf4885
crossref_primary_10_1007_s00432_021_03792_3
crossref_primary_10_1007_s43450_023_00378_7
crossref_primary_10_1016_j_jpha_2024_101092
crossref_primary_10_1016_j_jds_2025_03_012
crossref_primary_10_1093_jbmrpl_ziad014
crossref_primary_10_1016_j_ijbiomac_2025_139829
crossref_primary_10_1016_j_thromres_2024_05_002
crossref_primary_10_1097_MD_0000000000035365
crossref_primary_10_3389_fimmu_2024_1460282
crossref_primary_10_2174_0118715303286652240214110511
crossref_primary_10_1186_s12964_019_0461_0
crossref_primary_10_3390_ijms241612827
crossref_primary_10_1007_s12013_024_01366_x
crossref_primary_10_1016_j_tranon_2023_101816
crossref_primary_10_3390_cimb46070444
crossref_primary_10_1016_j_bbamcr_2021_118992
crossref_primary_10_1016_j_tox_2023_153598
crossref_primary_10_1002_ctm2_37
crossref_primary_10_3389_fphar_2022_977025
crossref_primary_10_1002_mco2_427
crossref_primary_10_1182_blood_2020006329
crossref_primary_10_18632_aging_203328
crossref_primary_10_1155_2019_6156493
crossref_primary_10_1016_j_adcanc_2021_100009
crossref_primary_10_1186_s40164_024_00566_8
crossref_primary_10_1016_j_prp_2023_154852
crossref_primary_10_1016_j_biopha_2023_115540
crossref_primary_10_1186_s12943_023_01877_w
crossref_primary_10_1158_1535_7163_MCT_21_0715
crossref_primary_10_1186_s12964_025_02052_y
crossref_primary_10_4081_aiua_2021_2_148
crossref_primary_10_1016_j_molimm_2023_10_001
crossref_primary_10_3389_fonc_2019_01359
crossref_primary_10_1016_j_semcancer_2024_10_003
crossref_primary_10_1080_13880209_2020_1839513
crossref_primary_10_1016_j_apsb_2023_10_002
crossref_primary_10_1016_j_brainres_2025_149528
crossref_primary_10_1016_j_ejmech_2023_115274
crossref_primary_10_1016_j_bbrep_2020_100726
crossref_primary_10_1084_jem_20200464
crossref_primary_10_1080_07391102_2024_2439578
crossref_primary_10_2147_OTT_S257606
crossref_primary_10_3390_cells10112833
crossref_primary_10_1002_pros_23871
crossref_primary_10_1016_j_envres_2023_117203
crossref_primary_10_1155_2019_7838195
crossref_primary_10_1177_1533033819892261
crossref_primary_10_1016_j_biopha_2023_115414
crossref_primary_10_1007_s00432_023_05420_8
crossref_primary_10_1007_s12272_019_01167_4
crossref_primary_10_1002_iub_2071
crossref_primary_10_3390_ijms20030581
crossref_primary_10_1016_j_jconrel_2022_03_055
crossref_primary_10_1080_14756366_2023_2295241
crossref_primary_10_1016_j_omtn_2020_07_005
crossref_primary_10_1007_s11030_024_11071_9
crossref_primary_10_1021_acs_jmedchem_2c00962
crossref_primary_10_1080_07391102_2020_1730968
crossref_primary_10_1158_0008_5472_CAN_18_2614
crossref_primary_10_1371_journal_pone_0293128
crossref_primary_10_3389_fonc_2022_1121120
crossref_primary_10_1016_j_psj_2024_103834
crossref_primary_10_1016_j_phymed_2025_156497
crossref_primary_10_1016_j_bbrc_2024_150268
crossref_primary_10_3389_fimmu_2024_1332818
crossref_primary_10_1016_j_lfs_2020_118687
crossref_primary_10_3390_ijms242316936
crossref_primary_10_3389_fimmu_2022_869676
crossref_primary_10_4103_NRR_NRR_D_23_01130
crossref_primary_10_1097_MD_0000000000037183
crossref_primary_10_1002_mc_23566
Cites_doi 10.1016/S1050-1738(00)00027-X
10.1038/onc.2012.355
10.1016/S0959-8049(01)00271-4
10.1038/ni.1937
10.1158/1541-7786.MCR-11-0569
10.1074/jbc.M107488200
10.1038/sj.onc.1202788
10.1038/nrc3847
10.1158/0008-5472.CAN-09-2997
10.1016/0049-3848(92)90048-F
10.1016/j.leukres.2013.07.026
10.1155/2013/238284
10.1152/ajpheart.00020.2004
10.1038/nbt0913-775a
10.1016/j.yjmcc.2004.06.018
10.1021/bi301588c
10.1016/j.bbrc.2013.05.019
10.1016/0092-8674(95)90520-0
10.1371/journal.pone.0002425
10.1089/105072502320908303
10.4174/jkss.2012.82.5.271
10.18632/oncoscience.218
10.1038/373623a0
10.1038/onc.2013.487
10.18632/oncotarget.2422
10.1002/jcp.20265
10.1016/j.oraloncology.2015.04.004
10.1016/j.cell.2010.03.014
10.1073/pnas.97.22.12260
10.1182/blood-2009-06-228684
10.1038/onc.2016.295
10.1186/1476-4598-10-139
10.1007/s10585-010-9367-3
10.1016/S0014-5793(97)00448-1
10.1042/bj3230387
10.1128/MCB.16.1.135
10.1615/CritRevImmunol.v32.i6.10
10.3171/2009.10.JNS08631
10.18632/oncotarget.2542
10.1586/17474086.2015.997704
10.1111/j.1349-7006.2009.01364.x
10.1159/000079499
10.1016/j.cell.2009.11.007
10.18632/oncotarget.8776
10.1073/pnas.1302507110
10.1182/blood-2009-10-251660
10.1038/sj.onc.1201123
10.1038/onc.2009.212
10.18632/oncotarget.2142
10.1172/JCI39325
10.1593/neo.91384
10.18632/oncotarget.3952
10.1074/jbc.M207340200
10.1016/j.semcdb.2008.02.001
10.1158/0008-5472.CAN-03-0245
10.1016/j.bbrc.2013.03.082
10.1007/s13277-010-0037-5
10.1073/pnas.0909333107
10.1074/jbc.271.47.30022
10.1016/S0092-8674(88)91065-3
10.1128/MCB.13.8.4976
10.1182/blood-2009-12-257154
10.1038/nri2528
10.1596/neo.111740
10.1158/0008-5472.CAN-06-4672
10.1158/0008-5472.CAN-10-2186
10.1038/nchembio.1636
10.1158/0008-5472.CAN-05-0993
10.7554/eLife.03385
10.1038/nature12998
10.1021/acs.nanolett.6b02995
10.1038/nrc2131
10.1038/bcj.2012.46
10.4049/jimmunol.1401933
10.1074/jbc.M112.384438
10.1182/blood-2013-03-491431
10.1038/nature21104
10.1371/journal.pone.0165107
10.1158/1078-0432.CCR-07-0862
10.1111/j.1471-4159.1993.tb03574.x
10.1371/journal.pone.0021811
10.1038/onc.2010.268
10.1038/onc.2013.40
10.1016/j.thromres.2009.09.011
10.1158/0008-5472.CAN-08-4490
10.1021/acs.jmedchem.5b01273
10.1038/sj.emboj.7600912
10.1177/039463201302600117
10.1158/0008-5472.CAN-05-4005
10.18632/oncotarget.2648
10.1002/cncr.25483
10.1016/j.bbamcr.2015.11.003
10.1038/onc.2012.587
10.1038/nri2356
10.1016/S0006-291X(02)02718-3
10.1038/nature12065
10.1002/1097-0142(19900201)65:3<481::AID-CNCR2820650318>3.0.CO;2-U
10.1593/neo.05640
10.1101/cshperspect.a009076
10.1172/JCI67816
10.1007/978-3-319-39406-0_5
ContentType Journal Article
Copyright COPYRIGHT 2018 BioMed Central Ltd.
The Author(s). 2018
Copyright_xml – notice: COPYRIGHT 2018 BioMed Central Ltd.
– notice: The Author(s). 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1186/s12943-018-0769-1
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1476-4598
EndPage 10
ExternalDocumentID oai_doaj_org_article_3d356bee0b564e1f9cd6f7d39e7f2550
PMC5793417
A546399398
29386018
10_1186_s12943_018_0769_1
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: National Natural Science Foundation of China
  grantid: 81600306
– fundername: China Postdoctoral Science Foundation
  grantid: 2015M572681
– fundername: National Natural Science Foundation of China
  grantid: 81500263
– fundername: China Postdoctoral Science Foundation
  grantid: 2016T90973
– fundername: ;
  grantid: 2016T90973
– fundername: ;
  grantid: 81600306
– fundername: ;
  grantid: 2015M572681
– fundername: ;
  grantid: 81500263
GroupedDBID ---
0R~
123
29M
2WC
53G
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HH5
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PZZ
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7X8
PPXIY
5PM
PJZUB
PUEGO
ID FETCH-LOGICAL-c532t-f8bcaf2c64cb848a31d93f8c643d64b5cd9ea84cb3852306b85f5aeaa67daa23
IEDL.DBID M48
ISSN 1476-4598
IngestDate Wed Aug 27 01:31:57 EDT 2025
Thu Aug 21 13:53:18 EDT 2025
Fri Jul 11 00:59:01 EDT 2025
Tue Jun 17 21:01:53 EDT 2025
Tue Jun 10 20:29:09 EDT 2025
Thu Apr 03 07:06:56 EDT 2025
Thu Apr 24 22:58:31 EDT 2025
Tue Jul 01 01:01:15 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Growth arrest-specific 6
Tumour microenvironment
Cancer cells
Language English
License Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-f8bcaf2c64cb848a31d93f8c643d64b5cd9ea84cb3852306b85f5aeaa67daa23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-1163-2359
OpenAccessLink https://doaj.org/article/3d356bee0b564e1f9cd6f7d39e7f2550
PMID 29386018
PQID 1993382781
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_3d356bee0b564e1f9cd6f7d39e7f2550
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5793417
proquest_miscellaneous_1993382781
gale_infotracmisc_A546399398
gale_infotracacademiconefile_A546399398
pubmed_primary_29386018
crossref_primary_10_1186_s12943_018_0769_1
crossref_citationtrail_10_1186_s12943_018_0769_1
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-31
PublicationDateYYYYMMDD 2018-01-31
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-31
  day: 31
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Molecular cancer
PublicationTitleAlternate Mol Cancer
PublicationYear 2018
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References C Gjerdrum (769_CR65) 2010; 107
J Han (769_CR21) 2013; 435
SK Biswas (769_CR51) 2010; 11
S Hafizi (769_CR31) 2002; 299
B Uygur (769_CR47) 2011; 10
Y Jung (769_CR9) 2012; 14
A Sufit (769_CR87) 2016; 11
R Nakayama (769_CR101) 2014; 38
B Baum (769_CR62) 2008; 19
JP Thiery (769_CR63) 2009; 139
S Zheng (769_CR103) 2015; 194
TC Cheong (769_CR98) 2010; 101
CD Mills (769_CR53) 2012; 32
MJ Streetly (769_CR99) 2010; 115
SH Myers (769_CR81) 2016; 59
M Janning (769_CR77) 2015; 8
K Nagata (769_CR20) 1996; 271
JA Hamilton (769_CR55) 2008; 8
A Wimmel (769_CR37) 2001; 37
C Sheridan (769_CR80) 2013; 31
MZ Wojtukiewicz (769_CR94) 1990; 65
M Murtaza (769_CR70) 2013; 497
X Wu (769_CR82) 2014; 5
CM Ghajar (769_CR60) 2016; 540
AB Lee-Sherick (769_CR41) 2016; 35
BC Varnum (769_CR18) 1995; 373
M Paolino (769_CR13) 2014; 507
H Axelrod (769_CR5) 2014; 5
L Bosurgi (769_CR104) 2013; 110
MG Melaragno (769_CR14) 2004; 37
BZ Qian (769_CR52) 2010; 141
RM Linger (769_CR22) 2013; 32
NS Nicholas (769_CR49) 2016; 1863
KW Chung (769_CR90) 2012; 82
LN Brandao (769_CR38) 2013; 3
MC Abba (769_CR27) 2007; 67
YW Fridell (769_CR43) 1996; 16
E Sierko (769_CR96) 2010; 125
I Hasanbasic (769_CR79) 2004; 287
M Buehler (769_CR8) 2013; 2013
KC Chiu (769_CR7) 2015; 51
M Ito (769_CR26) 2002; 12
Y Li (769_CR83) 2009; 28
S Ammoun (769_CR6) 2014; 33
A Abe (769_CR89) 1995; 9
S Loges (769_CR12) 2010; 115
T Sasaki (769_CR4) 2006; 25
RC Ekyalongo (769_CR23) 2014; 34
T Sasaki (769_CR17) 2002; 277
Z Ma (769_CR40) 2016; 7
SJ Holland (769_CR74) 2010; 70
S Goruppi (769_CR30) 1999; 18
M Vouri (769_CR78) 2015; 6
X Ye (769_CR85) 2010; 29
VM Faca (769_CR91) 2008; 3
PR van Ginkel (769_CR36) 2004; 64
I Dransfield (769_CR50) 2016; 930
DJ Phillips (769_CR93) 1993; 61
CT Cummings (769_CR88) 2014; 5
R Liu (769_CR84) 2010; 116
J Schlegel (769_CR39) 2013; 123
W Leconet (769_CR86) 2014; 33
C Maillard (769_CR97) 1992; 130
X Song (769_CR10) 2011; 117
G Lemke (769_CR102) 2013; 5
YS Shieh (769_CR32) 2005; 7
K Tanabe (769_CR3) 1997; 408
SJ Holland (769_CR66) 2005; 65
L Mirandola (769_CR100) 2011; 6
W Sun (769_CR69) 2004; 66
SJ Demarest (769_CR24) 2013; 52
TN Stitt (769_CR19) 1995; 80
M Emadi Baygi (769_CR46) 2010; 31
DK Graham (769_CR75) 2014; 14
H Takeuchi (769_CR57) 2010; 113
T Nakano (769_CR15) 1997; 323
M Hutterer (769_CR25) 2008; 14
SP Dormady (769_CR67) 2000; 97
A Mishra (769_CR68) 2012; 10
MS Kariolis (769_CR73) 2014; 10
G Manfioletti (769_CR1) 1993; 13
AB Lee-Sherick (769_CR42) 2013; 32
CE Lewis (769_CR56) 2006; 66
T Burstyn-Cohen (769_CR59) 2009; 119
Y Zhang (769_CR11) 2013; 26
M Yanagita (769_CR33) 2001; 276
Y Shiozawa (769_CR64) 2010; 12
MG Melaragno (769_CR58) 1999; 9
JW Pollard (769_CR54) 2009; 9
I Ben-Batalla (769_CR35) 2013; 122
H Peinado (769_CR45) 2007; 7
P Saraon (769_CR95) 2012; 287
B Yang (769_CR48) 2016; 16
WB Tsai (769_CR71) 2015; 2
C Schneider (769_CR16) 1988; 54
L Liu (769_CR72) 2009; 69
ED Fleuren (769_CR76) 2014; 5
Y Lee (769_CR44) 2013; 434
PP Sainaghi (769_CR28) 2005; 204
769_CR2
OR Odegaard (769_CR92) 1992; 66
J Braunger (769_CR29) 1997; 14
S Thomson (769_CR61) 2011; 28
E Avilla (769_CR34) 2011; 71
References_xml – volume: 9
  start-page: 250
  year: 1999
  ident: 769_CR58
  publication-title: Trends Cardiovasc Med
  doi: 10.1016/S1050-1738(00)00027-X
– volume: 32
  start-page: 3420
  year: 2013
  ident: 769_CR22
  publication-title: Oncogene
  doi: 10.1038/onc.2012.355
– volume: 37
  start-page: 2264
  year: 2001
  ident: 769_CR37
  publication-title: Eur J Cancer
  doi: 10.1016/S0959-8049(01)00271-4
– volume: 11
  start-page: 889
  year: 2010
  ident: 769_CR51
  publication-title: Nat Immunol
  doi: 10.1038/ni.1937
– volume: 10
  start-page: 703
  year: 2012
  ident: 769_CR68
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-11-0569
– volume: 276
  start-page: 42364
  year: 2001
  ident: 769_CR33
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M107488200
– volume: 18
  start-page: 4224
  year: 1999
  ident: 769_CR30
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1202788
– volume: 14
  start-page: 769
  year: 2014
  ident: 769_CR75
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3847
– volume: 70
  start-page: 1544
  year: 2010
  ident: 769_CR74
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-09-2997
– volume: 66
  start-page: 729
  year: 1992
  ident: 769_CR92
  publication-title: Thromb Res.
  doi: 10.1016/0049-3848(92)90048-F
– volume: 38
  start-page: 103
  year: 2014
  ident: 769_CR101
  publication-title: Leuk Res.
  doi: 10.1016/j.leukres.2013.07.026
– volume: 2013
  start-page: 238284
  year: 2013
  ident: 769_CR8
  publication-title: Biomed Res Int
  doi: 10.1155/2013/238284
– volume: 287
  start-page: H1207
  year: 2004
  ident: 769_CR79
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00020.2004
– volume: 31
  start-page: 775
  year: 2013
  ident: 769_CR80
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt0913-775a
– volume: 37
  start-page: 881
  year: 2004
  ident: 769_CR14
  publication-title: J Mol Cell Cardiol
  doi: 10.1016/j.yjmcc.2004.06.018
– volume: 52
  start-page: 3102
  year: 2013
  ident: 769_CR24
  publication-title: Biochemistry
  doi: 10.1021/bi301588c
– volume: 435
  start-page: 493
  year: 2013
  ident: 769_CR21
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.05.019
– volume: 80
  start-page: 661
  year: 1995
  ident: 769_CR19
  publication-title: Cell
  doi: 10.1016/0092-8674(95)90520-0
– volume: 3
  start-page: e2425
  year: 2008
  ident: 769_CR91
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0002425
– volume: 12
  start-page: 971
  year: 2002
  ident: 769_CR26
  publication-title: Thyroid
  doi: 10.1089/105072502320908303
– volume: 82
  start-page: 271
  year: 2012
  ident: 769_CR90
  publication-title: J Korean Surg Soc.
  doi: 10.4174/jkss.2012.82.5.271
– volume: 2
  start-page: 659
  year: 2015
  ident: 769_CR71
  publication-title: Oncoscience
  doi: 10.18632/oncoscience.218
– volume: 373
  start-page: 623
  year: 1995
  ident: 769_CR18
  publication-title: Nature
  doi: 10.1038/373623a0
– volume: 33
  start-page: 5405
  year: 2014
  ident: 769_CR86
  publication-title: Oncogene
  doi: 10.1038/onc.2013.487
– volume: 5
  start-page: 8818
  year: 2014
  ident: 769_CR5
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2422
– volume: 204
  start-page: 36
  year: 2005
  ident: 769_CR28
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20265
– volume: 51
  start-page: 683
  year: 2015
  ident: 769_CR7
  publication-title: Oral Oncol
  doi: 10.1016/j.oraloncology.2015.04.004
– volume: 141
  start-page: 39
  year: 2010
  ident: 769_CR52
  publication-title: Cell
  doi: 10.1016/j.cell.2010.03.014
– volume: 97
  start-page: 12260
  year: 2000
  ident: 769_CR67
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.97.22.12260
– volume: 115
  start-page: 2264
  year: 2010
  ident: 769_CR12
  publication-title: Blood
  doi: 10.1182/blood-2009-06-228684
– volume: 35
  start-page: 6270
  year: 2016
  ident: 769_CR41
  publication-title: Oncogene
  doi: 10.1038/onc.2016.295
– volume: 10
  start-page: 139
  year: 2011
  ident: 769_CR47
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-10-139
– volume: 28
  start-page: 137
  year: 2011
  ident: 769_CR61
  publication-title: Clin Exp Metastasis
  doi: 10.1007/s10585-010-9367-3
– volume: 408
  start-page: 306
  year: 1997
  ident: 769_CR3
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(97)00448-1
– volume: 323
  start-page: 387
  issue: Pt 2
  year: 1997
  ident: 769_CR15
  publication-title: Biochem J
  doi: 10.1042/bj3230387
– volume: 16
  start-page: 135
  year: 1996
  ident: 769_CR43
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.16.1.135
– volume: 32
  start-page: 463
  year: 2012
  ident: 769_CR53
  publication-title: Crit Rev Immunol
  doi: 10.1615/CritRevImmunol.v32.i6.10
– volume: 113
  start-page: 218
  year: 2010
  ident: 769_CR57
  publication-title: J Neurosurg
  doi: 10.3171/2009.10.JNS08631
– volume: 5
  start-page: 9546
  year: 2014
  ident: 769_CR82
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2542
– volume: 8
  start-page: 135
  year: 2015
  ident: 769_CR77
  publication-title: Expert Rev Hematol
  doi: 10.1586/17474086.2015.997704
– volume: 101
  start-page: 94
  year: 2010
  ident: 769_CR98
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2009.01364.x
– volume: 66
  start-page: 450
  year: 2004
  ident: 769_CR69
  publication-title: Oncology
  doi: 10.1159/000079499
– volume: 139
  start-page: 871
  year: 2009
  ident: 769_CR63
  publication-title: Cell
  doi: 10.1016/j.cell.2009.11.007
– volume: 7
  start-page: 46768
  year: 2016
  ident: 769_CR40
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8776
– volume: 110
  start-page: 13091
  year: 2013
  ident: 769_CR104
  publication-title: Proc Natl Acad Sci U S A.
  doi: 10.1073/pnas.1302507110
– volume: 115
  start-page: 3939
  year: 2010
  ident: 769_CR99
  publication-title: Blood.
  doi: 10.1182/blood-2009-10-251660
– volume: 14
  start-page: 2619
  year: 1997
  ident: 769_CR29
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1201123
– volume: 28
  start-page: 3442
  year: 2009
  ident: 769_CR83
  publication-title: Oncogene
  doi: 10.1038/onc.2009.212
– volume: 5
  start-page: 10434
  year: 2014
  ident: 769_CR88
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2142
– volume: 119
  start-page: 2942
  year: 2009
  ident: 769_CR59
  publication-title: J Clin Invest
  doi: 10.1172/JCI39325
– volume: 12
  start-page: 116
  year: 2010
  ident: 769_CR64
  publication-title: Neoplasia
  doi: 10.1593/neo.91384
– volume: 6
  start-page: 16183
  year: 2015
  ident: 769_CR78
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3952
– volume: 277
  start-page: 44164
  year: 2002
  ident: 769_CR17
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M207340200
– volume: 19
  start-page: 294
  year: 2008
  ident: 769_CR62
  publication-title: Semin Cell Dev Biol
  doi: 10.1016/j.semcdb.2008.02.001
– volume: 34
  start-page: 3337
  year: 2014
  ident: 769_CR23
  publication-title: Anticancer Res
– volume: 64
  start-page: 128
  year: 2004
  ident: 769_CR36
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-03-0245
– volume: 434
  start-page: 8
  year: 2013
  ident: 769_CR44
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2013.03.082
– volume: 31
  start-page: 297
  year: 2010
  ident: 769_CR46
  publication-title: Tumour Biol
  doi: 10.1007/s13277-010-0037-5
– volume: 107
  start-page: 1124
  year: 2010
  ident: 769_CR65
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0909333107
– volume: 271
  start-page: 30022
  year: 1996
  ident: 769_CR20
  publication-title: J Biol Chem
  doi: 10.1074/jbc.271.47.30022
– volume: 54
  start-page: 787
  year: 1988
  ident: 769_CR16
  publication-title: Cell
  doi: 10.1016/S0092-8674(88)91065-3
– volume: 13
  start-page: 4976
  year: 1993
  ident: 769_CR1
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.13.8.4976
– volume: 116
  start-page: 297
  year: 2010
  ident: 769_CR84
  publication-title: Blood
  doi: 10.1182/blood-2009-12-257154
– volume: 9
  start-page: 259
  year: 2009
  ident: 769_CR54
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2528
– volume: 14
  start-page: 429
  year: 2012
  ident: 769_CR9
  publication-title: Neoplasia
  doi: 10.1596/neo.111740
– volume: 67
  start-page: 4104
  year: 2007
  ident: 769_CR27
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-4672
– volume: 71
  start-page: 1792
  year: 2011
  ident: 769_CR34
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-10-2186
– volume: 10
  start-page: 977
  year: 2014
  ident: 769_CR73
  publication-title: Nat Chem Biol
  doi: 10.1038/nchembio.1636
– volume: 65
  start-page: 9294
  year: 2005
  ident: 769_CR66
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-0993
– ident: 769_CR2
  doi: 10.7554/eLife.03385
– volume: 507
  start-page: 508
  year: 2014
  ident: 769_CR13
  publication-title: Nature
  doi: 10.1038/nature12998
– volume: 130
  start-page: 1599
  year: 1992
  ident: 769_CR97
  publication-title: Endocrinology.
– volume: 16
  start-page: 5951
  year: 2016
  ident: 769_CR48
  publication-title: Nano Lett
  doi: 10.1021/acs.nanolett.6b02995
– volume: 7
  start-page: 415
  year: 2007
  ident: 769_CR45
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2131
– volume: 3
  start-page: e101
  year: 2013
  ident: 769_CR38
  publication-title: Blood Cancer J
  doi: 10.1038/bcj.2012.46
– volume: 194
  start-page: 1928
  year: 2015
  ident: 769_CR103
  publication-title: J Immunol.
  doi: 10.4049/jimmunol.1401933
– volume: 287
  start-page: 34019
  year: 2012
  ident: 769_CR95
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.M112.384438
– volume: 122
  start-page: 2443
  year: 2013
  ident: 769_CR35
  publication-title: Blood
  doi: 10.1182/blood-2013-03-491431
– volume: 540
  start-page: 528
  year: 2016
  ident: 769_CR60
  publication-title: Nature.
  doi: 10.1038/nature21104
– volume: 11
  start-page: e0165107
  year: 2016
  ident: 769_CR87
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0165107
– volume: 14
  start-page: 130
  year: 2008
  ident: 769_CR25
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-0862
– volume: 61
  start-page: 344
  year: 1993
  ident: 769_CR93
  publication-title: J Neurochem.
  doi: 10.1111/j.1471-4159.1993.tb03574.x
– volume: 6
  start-page: e21811
  year: 2011
  ident: 769_CR100
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0021811
– volume: 29
  start-page: 5254
  year: 2010
  ident: 769_CR85
  publication-title: Oncogene
  doi: 10.1038/onc.2010.268
– volume: 32
  start-page: 5359
  year: 2013
  ident: 769_CR42
  publication-title: Oncogene
  doi: 10.1038/onc.2013.40
– volume: 125
  start-page: e71
  year: 2010
  ident: 769_CR96
  publication-title: Thromb Res.
  doi: 10.1016/j.thromres.2009.09.011
– volume: 9
  start-page: 341
  year: 1995
  ident: 769_CR89
  publication-title: Leukemia.
– volume: 69
  start-page: 6871
  year: 2009
  ident: 769_CR72
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-4490
– volume: 59
  start-page: 3593
  year: 2016
  ident: 769_CR81
  publication-title: J Med Chem
  doi: 10.1021/acs.jmedchem.5b01273
– volume: 25
  start-page: 80
  year: 2006
  ident: 769_CR4
  publication-title: EMBO J
  doi: 10.1038/sj.emboj.7600912
– volume: 26
  start-page: 179
  year: 2013
  ident: 769_CR11
  publication-title: Int J Immunopathol Pharmacol
  doi: 10.1177/039463201302600117
– volume: 66
  start-page: 605
  year: 2006
  ident: 769_CR56
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-05-4005
– volume: 5
  start-page: 12753
  year: 2014
  ident: 769_CR76
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.2648
– volume: 117
  start-page: 734
  year: 2011
  ident: 769_CR10
  publication-title: Cancer
  doi: 10.1002/cncr.25483
– volume: 1863
  start-page: 471
  year: 2016
  ident: 769_CR49
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbamcr.2015.11.003
– volume: 33
  start-page: 336
  year: 2014
  ident: 769_CR6
  publication-title: Oncogene
  doi: 10.1038/onc.2012.587
– volume: 8
  start-page: 533
  year: 2008
  ident: 769_CR55
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2356
– volume: 299
  start-page: 793
  year: 2002
  ident: 769_CR31
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/S0006-291X(02)02718-3
– volume: 497
  start-page: 108
  year: 2013
  ident: 769_CR70
  publication-title: Nature
  doi: 10.1038/nature12065
– volume: 65
  start-page: 481
  year: 1990
  ident: 769_CR94
  publication-title: Cancer.
  doi: 10.1002/1097-0142(19900201)65:3<481::AID-CNCR2820650318>3.0.CO;2-U
– volume: 7
  start-page: 1058
  year: 2005
  ident: 769_CR32
  publication-title: Neoplasia
  doi: 10.1593/neo.05640
– volume: 5
  start-page: a009076
  year: 2013
  ident: 769_CR102
  publication-title: Cold Spring Harb Perspect Biol.
  doi: 10.1101/cshperspect.a009076
– volume: 123
  start-page: 2257
  year: 2013
  ident: 769_CR39
  publication-title: J Clin Invest
  doi: 10.1172/JCI67816
– volume: 930
  start-page: 113
  year: 2016
  ident: 769_CR50
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-39406-0_5
SSID ssj0017874
Score 2.552506
SecondaryResourceType review_article
Snippet Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in growth-arrested...
Abstract Growth arrest-specific 6, also known as Gas6, is a human gene encoding the Gas6 protein, which was originally found to be upregulated in...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 20
SubjectTerms Analysis
Animals
Axl Receptor Tyrosine Kinase
Biomarkers, Tumor
c-Mer Tyrosine Kinase - antagonists & inhibitors
c-Mer Tyrosine Kinase - metabolism
Cancer
Cancer cells
Care and treatment
Cell Line, Tumor
Cell Proliferation
Cell Survival - genetics
Fibroblasts
Growth arrest-specific 6
Humans
Intercellular Signaling Peptides and Proteins - genetics
Intercellular Signaling Peptides and Proteins - metabolism
Metastasis
Molecular Targeted Therapy
Neoplasm Metastasis
Neoplasm Staging
Neoplasms - drug therapy
Neoplasms - genetics
Neoplasms - metabolism
Neoplasms - pathology
Proto-Oncogene Proteins - antagonists & inhibitors
Proto-Oncogene Proteins - metabolism
Receptor Protein-Tyrosine Kinases - antagonists & inhibitors
Receptor Protein-Tyrosine Kinases - metabolism
Review
Tumor Microenvironment - drug effects
Tumor Microenvironment - genetics
Tumour microenvironment
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3daxQxEA9SqPgitmo9WyWCUBDCNZuPTR5PsR7C-XSFvoV8YqHdK_fx0P--M7t7xy1C--LjZpIlmUwyM8nkN4R8zRZsUJsj41l4Jr0ILEQdmC0qQXmtZGrRPv_o6ZX8fa2u91J9YUxYBw_cMW4sklA65HwRlJaZFxuTLnUS8J8C5nDrrYPO2zpT_f0BiKHs7zC50eMVaDWJcUOGgd9uGR9ooRas_98teU8nDeMl9xTQ5Rvyurcc6aTr8RF5kZtjctjlknw4Ji9n_S35WwJuOJ5zg1Kiv_xKj-eTGb1paMQJXlI8ql9R3yS63twtlvQOQ_L23ru9I_PLn_MfU9anSWBRiWrNignRlypqGYORxguerCgGvkXSMqiYbPYGiMLgEbAORhXls_e6Tt5X4j05aBZN_kBozsHaiEabrKSQMgCrZR1LVnWSkdsRudhyzcUeQhwzWdy61pUw2nWMdsBoh4x2fES-7Zrcd_gZT1X-jlOxq4jQ120BCITrBcI9JxAjco4T6XCBQuei798ZwBAR6spNMAEAWGXWjMjZoCYsrDggf9mKgkMSRqM1ebFZOQx6FKaqDfT4pBONXZ_BfDLg5ELreiA0g0ENKc3N3xbXW8FeKXn98X9w4ZS8qlpx56Blz8jBernJn8B8WofP7Up5BF5VFvM
  priority: 102
  providerName: Directory of Open Access Journals
Title Targeting Gas6/TAM in cancer cells and tumor microenvironment
URI https://www.ncbi.nlm.nih.gov/pubmed/29386018
https://www.proquest.com/docview/1993382781
https://pubmed.ncbi.nlm.nih.gov/PMC5793417
https://doaj.org/article/3d356bee0b564e1f9cd6f7d39e7f2550
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEF9qi-KLaP06rUcEQRDWXrLfDyJXaS0HV0SvcG_LfqUW2pwmd2D_e2c3ufOCpU8h2d0wO_nNzszuZAahd0GBDaqCw3kgBlNDLLaOW6xK5uG5YNSnbJ9n_PScTuZsvoPW5a06Bja3unaxntR5ffXxz--bzyDwn5LAS37YgM6iMSpIYvDKFQZnaA8Uk4hyOqX_DhUAm-mQmQqOKVOyO-S89RU9NZWy-f-_Zm8prX5A5ZaGOnmMHnWmZTZusfAE7YRqH91vi03e7KMH0-4Y_SkCPz1uhIPWyr6ahh_OxtPssspcRECdxb38JjOVz5ar60WdXceYva0f4p6h2cnx7Msp7uooYMdIscSltM6UhePUWUmlIblXpJRwTzynljmvgpHQSGTcI-ZWspKZYAwX3piCPEe71aIKL1EWglXKRauOFpRQaj0vqXBlYMJTl6sBGq25pl2XYzyWurjSydeQXLeM1sBoHRmt8wH6sBnyq02wcVfno_gpNh1jbuz0YFFf6E7UNPGEcRvCyDJOQ14qB1QKTwB5JThQowF6Hz-kjpgC4pzpfkSAKcZcWHocKwSA2abkAB30eoLkuV7z2zUUdGyK4WpVWKwaHaMiiSyEBIpftNDY0Az2lQQvGEaLHmh6k-q3VJc_U-JvBosp4PrV3WS9Rg-LBOQcFOwB2l3Wq_AGLKelHaJ7Yi6GaG88nvyYwPXo-Ozb92HahxgmWfkLuh4Xkw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Targeting+Gas6%2FTAM+in+cancer+cells+and+tumor+microenvironment&rft.jtitle=Molecular+cancer&rft.au=Wu%2C+Guiling&rft.au=Ma%2C+Zhiqiang&rft.au=Cheng%2C+Yicheng&rft.au=Hu%2C+Wei&rft.date=2018-01-31&rft.pub=BioMed+Central+Ltd&rft.issn=1476-4598&rft.eissn=1476-4598&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12943-018-0769-1&rft.externalDocID=A546399398
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-4598&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-4598&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-4598&client=summon